Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins
Autor: | Emna Ayari-Fakhfakh, Catherine Cetre-Sossah, Abdeljelil Ghram, Emmanuel Albina |
---|---|
Přispěvatelé: | Institut de Recherche Vétérinaire de Tunisie (IRVT), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP), Université Tunis El Manar (UTM), Animal, Santé, Territoires, Risques et Ecosystèmes (UMR ASTRE), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA), This study was partially funded by the French Minsitry of European and Foreign Affairs (FSP project N°2003-24 'LABOVET')., We wish to acknowledge N. Richard, T. Macotta, C. Le Goff, O. Kwiatek, P. Totté and M. Jego for their technical assistance and G. Libeau for her expertise on PPR., Université de Tunis El Manar (UTM), Institut National de la Recherche Agronomique (INRA)-Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad) |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
viruses animal diseases Antibodies Viral L73 - Maladies des animaux Capripoxvirus MESH: Viral Vaccines/genetics MESH: Antibodies Viral/blood 0302 clinical medicine Immunogenicity Vaccine Viral Envelope Proteins MESH: Vaccination/veterinary MESH: Recombinant Proteins/immunology MESH: Animals MESH: Cytokines/immunology Rift Valley fever Neutralizing antibody Immunogenicity Goats Vaccination MESH: Immunogenicity Vaccine Recombinant Proteins 3. Good health medicine.anatomical_structure [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology MESH: Viral Envelope Proteins/immunology Cytokines MESH: Rift Valley fever virus 030231 tropical medicine Immunology MESH: Antibodies Neutralizing/blood Biology MESH: Goats 03 medical and health sciences Immune system Immunity medicine Animals Immune response B cell MESH: Rift Valley Fever/prevention & control [SDV.BA.MVSA]Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health General Veterinary MESH: Capripoxvirus Viral Vaccines MESH: Viral Vaccines/immunology MESH: Rift Valley Fever/immunology biology.organism_classification medicine.disease Rift Valley fever virus Virology Antibodies Neutralizing 030104 developmental biology biology.protein |
Zdroj: | Veterinary Immunology and Immunopathology Veterinary Immunology and Immunopathology, Elsevier, 2018, 197, pp.15--20. ⟨10.1016/j.vetimm.2018.01.001⟩ |
ISSN: | 0165-2427 |
DOI: | 10.1016/j.vetimm.2018.01.001⟩ |
Popis: | International audience; The mosquito-borne Rift Valley fever virus (RVFV) causes severe diseases in domesticated animals including cattle, sheep, camels and goats. Capripoxviruses (CPV) are suitable vectors for multivalent vaccine development. A recombinant rKS1-based CPV expressing the gene encoding the viral glycoprotein Gn of RVFV has been shown to induce protection in mice and sheep. The aim of this study was to evaluate the immunogenicity induced by this candidate vaccine in goats, and the level of cytokines produced by RVFV-specific Th1 and Th2 lymphocytes. The results of this study suggest that Th2 mediates immunity mainly through the significant production of IL4, which, coupled with a decrease in IFN-γ, may be involved in the replication of the capripoxvirus expressing the GN of RVFV. CD4+ cells may play the role of helper cells in B cell responses and neutralizing antibody production in the anti-CPV humoral response, leading to strong immunity against RVFV. |
Databáze: | OpenAIRE |
Externí odkaz: |